SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-24-000055
Filing Date
2024-05-10
Accepted
2024-05-10 16:02:13
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20240331.htm   iXBRL 10-Q 670926
2 EX-10.1 skye-20240331xex10x1.htm EX-10.1 218320
3 EX-31.1 skye-20240331xex311.htm EX-31.1 10489
4 EX-31.2 skye-20240332xex312.htm EX-31.2 11018
5 EX-32.1 skye-20240331xex321.htm EX-32.1 5070
6 EX-32.2 skye-20240331xex322.htm EX-32.2 5210
  Complete submission text file 0001516551-24-000055.txt   4481878

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20240331.xsd EX-101.SCH 36904
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20240331_cal.xml EX-101.CAL 54343
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20240331_def.xml EX-101.DEF 170492
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20240331_lab.xml EX-101.LAB 397151
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20240331_pre.xml EX-101.PRE 289127
66 EXTRACTED XBRL INSTANCE DOCUMENT skye-20240331_htm.xml XML 467990
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42009 | Film No.: 24934660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)